Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas
Open Access
- 25 July 2002
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (16) , 1093-1100
- https://doi.org/10.1038/sj.gt.3301775
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)Nature Medicine, 2000
- An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyNature Medicine, 2000
- Heparan Sulfate Glycosaminoglycans Are Involved in Adenovirus Type 5 and 2-Host Cell InteractionsVirology, 2000
- Free Cholesterol Enhances Adenoviral Vector Gene Transfer and Expression in CAR-Deficient CellsMolecular Therapy, 2000
- Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouseCancer Gene Therapy, 1999
- Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cellsThe EMBO Journal, 1997
- Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5Science, 1997
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996
- Expression and Localization of αv Integrins and Their Ligand Vitronectin in Normal Ovarian Epithelium and in Ovarian CarcinomaGynecologic Oncology, 1996
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993